Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach

SIMPLE SUMMARY: About 30% of patients with medulloblastoma experience recurrence, which is usually incurable despite intensive chemotherapy. The aim of our retrospective study was to evaluate a novel combinatorial metronomic antiangiogenic approach (“MEMMAT-like”) for recurrent medulloblastoma consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Slavc, Irene, Mayr, Lisa, Stepien, Natalia, Gojo, Johannes, Aliotti Lippolis, Maria, Azizi, Amedeo A., Chocholous, Monika, Baumgartner, Alicia, Hedrich, Cora S., Holm, Stefan, Sehested, Astrid, Leblond, Pierre, Dieckmann, Karin, Haberler, Christine, Czech, Thomas, Kool, Marcel, Peyrl, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601092/
https://www.ncbi.nlm.nih.gov/pubmed/36291912
http://dx.doi.org/10.3390/cancers14205128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601092/
https://www.ncbi.nlm.nih.gov/pubmed/36291912
http://dx.doi.org/10.3390/cancers14205128

Ejemplares similares